ByHeart is an NYC-based infant nutrition company that uses breast milk science to develop clinically proven products. Its formulas are positioned to deliver benefits such as easier digestion, less spit up, softer poops, more efficient weight gain and enhanced nutrient absorption. The company operates end-to-end manufacturing facilities in Pennsylvania, Oregon, and Iowa, enabling full control over production and quality. ByHeart is a three-time Clean Label Project Certified brand and is led by CEO Ron Belldegrun. It recently launched in Thrive Market and plans to expand to several additional retailers by the end of 2024. The company raised $95M to support its U.S. commercial launch and the development of its innovation pipeline, bringing total funding to $395M to date. ByHeart is advancing an infant formula recipe that incorporates modern advancements in baby nutrition. The company plans to use its Series B proceeds to launch its first formula and to advance its innovation pipeline of mom and baby products. It recently launched Cluster, a digital platform offering resources and education to support parents from pregnancy through toddlerdom. ByHeart was founded in 2016 by Ron Belldegrun and Mia Funt and is based in New York City. The company operates manufacturing facilities in Pennsylvania. It raised $90M in Series B financing to fund these initiatives. ByHeart develops infant and baby nutrition products, including baby foods and formulas grounded in nutrition science and production transparency. The company targets immune, cognitive, digestive and microbiome health. Co-founded in 2016 by Mia Funt and Ron Belldegrun, ByHeart is based in New York City and operates facilities in Pennsylvania. It is conducting a multi-site infant-growth monitoring clinical study in accordance with FDA requirements to support a first product launch in 2021. The company closed a $70M Series A and is using the funds to continue to expand its development efforts.

Total raised

$255M

Funding rounds

3

Latest round

Equity

Latest activity

May 2024